XBiotech Mutual Funds | StatInvestor

Health Care & Life Sciences » Biotechnology | XBiotech Inc.

XBiotech Inc. | Mutual Funds

Mutual Funds that own XBiotech Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Vanguard Total Stock Market Index Fund

379,164

1.07%

07/31/2018

Vanguard Extended Market Index Fund

306,794

0.86%

07/31/2018

Fidelity Spartan Extended Market Index Fund

79,667

0.22%

07/31/2018

iShares Micro Cap ETF

53,549

0.15%

0.02%

09/06/2018

Schwab US Small Cap ETF

53,075

0.15%

09/06/2018

Vanguard Health Care Index Fund

43,230

0.12%

360

07/31/2018

Fidelity Spartan Small Cap Index Fund

39,372

0.11%

2,849

04/30/2018

CREF Stock Account

37,320

0.11%

03/31/2018

Fidelity Spartan Total Market Index Fund

36,998

0.1%

07/31/2018

Vanguard Institutional Total Stock Market Index Fund

30,917

0.09%

07/31/2018

About XBiotech

View Profile

Address	5217 Winnebago Lane Austin Texas 78744 United States
Employees	-
Website	http://www.xbiotech.com
Updated	07/08/2019
XBiotech, Inc. is a biopharmaceutical company, which engages in discovering and developing True Human monoclonal antibodies for treating diseases. It offers MABp1, which targets and neutralizes interleukin-1 alpha, a molecule known to promote angiogenesis, growth and spread of tumors, as well as mediate symptoms such as metabolic dysregulation, fatigue, and anxiety associated with advanced cancer. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.